Cargando…
Spontaneous intermuscular hematoma in a patient receiving ticagrelor and aspirin: A case report
Dual antiplatelet therapy is a cornerstone treatment following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Ticagrelor, a direct-acting potent P2Y12 inhibitor, is superior to clopidogrel in the acute setting of ACS: due to its faster onset and potent antiplatelet inhib...
Autores principales: | Yoon, Byung Woo, Hong, Ji Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780748/ https://www.ncbi.nlm.nih.gov/pubmed/33408862 http://dx.doi.org/10.3892/br.2020.1404 |
Ejemplares similares
-
Spontaneous hematoma in the setting of dual anti-platelet therapy with ticagrelor: A case report
por: FENG, CHUNGUANG, et al.
Publicado: (2016) -
Aspirin/ticagrelor: Haemoperitoneum and hepatic subcapsular haematoma: 2 case reports
Publicado: (2021) -
Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021) -
Spontaneous subdural hematoma and antiplatelet therapy: Does efficacy of Ticagrelor come with added risk?
por: Suryanarayana Sharma, Pattanagere Manjunatha, et al.
Publicado: (2015) -
Spontaneous Pulmonary Hematoma with No Underlying Causes: A Case Report
por: Lee, Eun Joo, et al.
Publicado: (2015)